Blood Advances · 2018 · 40 citations · 32 references
MedicineNuclear MedicineOncologyDiagnostic ImagingMolecular ImagingOncologic ImagingComputed TomographyImaging BiomarkersMedical ImagingPositron Emission TomographyPost-therapy ImagingTherapy Response AssessmentOncologic Pet ImagingPet QuantificationPet Response CriteriaPet-computed TomographyPositron Emission Tomography FindingsPositron Emission Tomography PrognosisPositron Emission Tomography Response AssessmentWhole-body Pet Imaging
Key Points Biomarkers are needed to identify patients with PMBCL who will not be cured after single-modality therapy with R-EPOCH. Volume-based and metabolic variables on pre- and postchemotherapy PET-CT seem to identify patients who progress after R-EPOCH alone.
32
Bayesian Model Selection in Social Research
Adrian E. Raftery · Sociological Methodology · 1995 · 6.9K citations
Computing, Biostatistics, Sociology +17
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.9K citations · Full text
Medicine, Hematology, Oncology +16
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
New England Journal of Medicine · 1993 · 5K citations · Full text
Medicine, Oncology, Chemotherapy +15